The anti-tumor effect of PARPi has been attributed to their ability to inhibit DNA repair and to trap PARP on DNA and ultimately induce DSB formation, with the former mechanism thought to be more HR deficiency-specific [22, 25–28]. The gene discussed is PARP1; the disease is neoplasm.